Cancer cells with higher SLC7A11 expression levels may be highly dependent on certain nutrients—such as glucose and glutamine—for survival, which can inform therapeutic strategies to target these cancer-specific metabolic vulnerabilities. Here, SLC7A11 is linked to cancer.